Basic Information | Post buying leads | Suppliers |
Name |
Asparkam |
EINECS | N/A |
CAS No. | 14842-81-0 | Density | g/cm3 |
PSA | 310.35000 | LogP | -5.28420 |
Solubility | N/A | Melting Point |
N/A |
Formula | C8H10MgN2O8•C4H7NO4•2H•K | Boiling Point | 264.1°Cat760mmHg |
Molecular Weight | 460.75 | Flash Point | 113.5°C |
Transport Information | N/A | Appearance | N/A |
Safety | Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
L-Aspartic acid,compounds,monopotassium salt,mixt. with dihydrogen (T-4)-bis[L-aspartato(2-)-kN,kO1]magnesate- (2-);Spartase;Aspara;Trophicard;L-Asparkam;MAGNESIUM POTASSIUM-l-ASPARTATE;ASPARTAT; |
Molecular Structure of Asparkam (CAS NO.14842-81-0):
IUPAC Name: magnesium; potassium; (2S)-2-amino-4-hydroxy-4-oxobutanoate; 2-amino-4-hydroxy-4-oxobutanoate
Empirical Formula: C12H18KMgN3O12
Molecular Weight: 459.6875
Flash Point: 113.5 °C
Enthalpy of Vaporization: 55.26 kJ/mol
Boiling Point: 264.1 °C at 760 mmHg
Vapour Pressure: 0.00289 mmHg at 25°C
Classification Code : Drug / Therapeutic Agent ; Nutrient
Synonyms of Asparkam (CAS NO.14842-81-0): L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-N,O(sup 1)magnesate(2-) ; L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-kappaN,kappaO1)magnesate(2-) ; L-Asparkam ; Aspartic acid, L-, magnesium salt (2:1) tetrahydrate, mixture with potassium hydrogen L-aspartate hemihydrate ; Asparkam ; Aspara
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 817mg/kg (817mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
mouse | LD50 | subcutaneous | 4226mg/kg (4226mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
rat | LD50 | intraperitoneal | > 2gm/kg (2000mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967. | |
rat | LD50 | intravenous | 619mg/kg (619mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. | |
rat | LD50 | subcutaneous | 6902mg/kg (6902mg/kg) | Drugs in Japan Vol. 6, Pg. 11, 1982. |
Magnesium potassium aspartate (CAS NO.14842-81-0) was reported in NIIRDN Drugs in Japan (Ethical Drugs).
Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O.